All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Security
Security
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter
First reported by bulkorder.ftc.gov
FTC Secures Major Settlement with Caremark, Resolving Antitrust Case Against Second Drug Middleman

FTC’s Settlement With CVS Caremark is Another Win For Big Medicine

The post FTC’s Settlement With CVS Caremark is Another Win For Big Medicine appeared first on American Economic Liberties Project .

Read the full article

You might also wanna read

FTC Secures Major Settlement with Caremark, Resolving Antitrust Case Against Second Drug Middleman

Settlement will drive down patients’ out-of-pocket costs, increase transparency and ensure community pharmacies are treated fairly The Feder

bulkorder.ftc.gov·2d ago

CVS settles with FTC, agrees to count TrumpRx drug purchases towards insurance

By Amina Niasse and Jody Godoy NEW YORK, July 14 (Reuters) - CVS Health's Caremark has finalized a settlement with the U.S. Federal Trade Co

KELO-AM·2d ago

STAT+: FTC settles lawsuit with CVS Caremark over charges it manipulated insulin prices, impeded access

The FTC settled a lawsuit against CVS Caremark over allegations that the company artificially inflated the price of insulin and impeded acce

STAT·2d ago

CVS Caremark reaches settlement with FTC over insulin suit

Terms of the deal announced Tuesday are very similar to those the FTC reached with Express Scripts earlier this year, including requiring th

Healthcare Dive·2d ago

FTC settles lawsuit with Optum Rx, ending its campaign against the ‘big three’ PBMs

The agency had been suing the three largest pharmacy benefit managers over their alleged control of insulin prices. It reached agreements wi

healthexec.com·1mo ago

The US FTC settles with a major pharmacy benefit manager over insulin rebating practices that inflated drug list prices (Caremark)

On 14 July 2026, the US Federal Trade Commission announced a proposed consent settlement with Caremark Rx and its affiliate Zinc Health Serv

concurrences.com·1d ago

Comments

Sign in to join the conversation.

No comments yet. Be the first.